Calfactant: A Review of its Use in Neonatal Respiratory Distress Syndrome

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.1, Iss.3, 1999-07, pp. : 219-243

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lucinactant in neonatal respiratory distress syndrome: profile report

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Current Perspectives on the Drug Treatment of Neonatal Respiratory Distress Syndrome

By Sweet D.G. Halliday H.L.

Pediatric Drugs, Vol. 1, Iss. 1, 1999-01 ,pp. : 19-30

Adis International

Access to resources Recommend Favorite

Lung Surfactants for Neonatal Respiratory Distress Syndrome: Animal-Derived or Synthetic Agents?

By Suresh G.K. Soll R.F.

Pediatric Drugs, Vol. 4, Iss. 8, 2002-01 ,pp. : 485-492

Adis International

Access to resources Recommend Favorite

A Risk-Benefit Assessment of Natural and Synthetic Exogenous Surfactants in the Management of Neonatal Respiratory Distress Syndrome

By Walti H. Monset-Couchard M.

Drug Safety, Vol. 18, Iss. 5, 1998-05 ,pp. : 321-337

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of acute respiratory distress syndrome

By Santos CC dos Slutsky AS Chant C

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 875-888

Informa Healthcare

Access to resources Recommend Favorite